Sequential measurement of fecal parameters in a case of non-immunoglobulin E-mediated milk allergy

2007 ◽  
Vol 49 (1) ◽  
pp. 109-111 ◽  
Author(s):  
HIDEO WADA ◽  
TORU HORISAWA ◽  
MASAYUKI INOUE ◽  
TOMOHIRO YOSHIDA ◽  
TOMOKO TOMA ◽  
...  
Keyword(s):  
Immunoglobulin E ◽  
Milk Allergy ◽  
Sequential Measurement

Feeding a soy formula to children with cow's milk allergy: The development of immunoglobulin E-mediated allergy to soy and peanuts

2005 ◽  
Vol 16 (8) ◽  
pp. 641-646 ◽  
Author(s):  
Timo Klemola ◽  
Kirsti Kalimo ◽  
Tuija Poussa ◽  
Kaisu Juntunen-Backman ◽  
Riitta Korpela ◽  
...  
Keyword(s):  
Immunoglobulin E ◽  
Cow’S Milk Allergy ◽  
Cow’S Milk ◽  
Milk Allergy ◽  
Cow's Milk ◽  
Cow's Milk Allergy

Immunoglobulin E and Immunoglobulin G4 Antibodies to Cow's Milk in Children with Cow's Milk Allergy

Allergy ◽  
1983 ◽  
Vol 38 (2) ◽  
pp. 119-124 ◽  
Author(s):  
Bengt Björkstéan ◽  
Staffan Ahlstedt ◽  
Fred Björkstéan ◽  
Barbro Carlsson ◽  
Sven Petter Fällström ◽  
...  
Keyword(s):  
Immunoglobulin E ◽  
Cow’S Milk Allergy ◽  
Cow’S Milk ◽  
Milk Allergy ◽  
Immunoglobulin G4 ◽  
Cow's Milk ◽  
Cow's Milk Allergy

Oral desensitization in children with immunoglobulin E-mediated cows milk allergy follow-up at 4yr and 8months

2008 ◽  
Vol 19 (5) ◽  
pp. 412-419 ◽  
Author(s):  
Paolo Meglio ◽  
Paolo G. Giampietro ◽  
Simona Gianni ◽  
Elena Galli
Keyword(s):  
Immunoglobulin E ◽  
Milk Allergy ◽  
Oral Desensitization

A new score to predict allergic march in patients with IgE‐mediated cow milk allergy

2019 ◽  
Vol 40 (3) ◽  
pp. 187-192 ◽  
Author(s):  
Francisco Gil ◽  
Mikel Mendizabal ◽  
Ana Amezqueta ◽  
Elena Aznal ◽  
Teodoro Durá ◽  
...  
Keyword(s):  
Immunoglobulin E ◽  
Allergic Diseases ◽  
Cow Milk ◽  
Multivariate Logistic Regression Model ◽  
High Grade ◽  
Milk Allergy ◽  
Increased Risk ◽  
Cow Milk Allergy ◽  
Ige Mediated ◽  
Allergic March

Background: Cow milk allergy (CMA) is the most common food allergy in infants. Some patients will express, in the future, other allergic diseases (allergic march). Objective: To evaluate if a new scoring system could determine the risk of developing allergic march. Methods: A retrospective observational cohort study of subjects who were immunoglobulin E (IgE) mediated was conducted. We defined a risk score for atopy (RSA), including clinical and laboratory variables. Three risk groups were defined according to the RSA. We defined as dependent variables atopy (one or more allergic diseases) and atopy+ (two or more allergic diseases). A multivariate logistic regression model was created, which included RSA and the type of formula (high-grade extended hydrolyzed formula [EHF] with Lactobacillus rhamnosus GG (LGG), high-grade EHF without LGG, and other formulas). Results: A total of 211 patients were recruited. When we analyzed the risk of atopy+, we found an increased risk for RSA intermediate-risk (odds ratio [OR 2.08] [95% confidence interval {CI}, 0.95‐4.56) and high-risk (OR 24.74 [95% CI, 6.26‐97.73]) groups, and a decreased risk for the subjects fed with high-grade EHF (OR 0.42 [95% CI, 0.20‐0.87]) and also in those subjects fed with high-grade EHF plus LGG (OR 0.30 [95% CI, 0.09‐0.98]). Conclusion: RSA is a simple and useful tool to predict the risk of developing other allergic diseases in patients with IgE-mediated CMA.

Sign in / Sign up

Export Citation Format

Share Document